SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242
http://www.w3.org/2000/01/rdf-schema#comment
"SK1 is a key regulator of anti-tumor immunity. Increased expression of SK1 in tumor cells is significantly associated with shorter survival in metastatic melanoma patients treated with anti-PD-1."
xsd:string
http://purl.uniprot.org/uniprot/#_F07C20E515719BF8D078690BB322D71A86CFA53DB4E548729F70AA12C9EC60A559A27063BDBC02A53FACC5513F1B1F4C
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242
http://purl.uniprot.org/uniprot/Q9BTG7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242
http://purl.uniprot.org/uniprot/#_Q9BTG7-mappedCitation-31974367
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F3952F198C30DBB50A088985BC424283AFE4E3E42B98B9A06AC1396C1A34B169DFA9E5E24F7DC5B0739AE0C1A7A91242